Skip to main content
Top
Published in: Supportive Care in Cancer 5/2024

Open Access 01-05-2024 | Fatigue | Research

Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis

Authors: Lena J. Lee, Claire J. Han, Leorey Saligan, Gwenyth R. Wallen

Published in: Supportive Care in Cancer | Issue 5/2024

Login to get access

Abstract

Purpose

Research on symptom clusters in oncology is progressing, but knowledge gaps remain. One question is whether the number and types of symptom subgroups (i.e., latent classes) differ based on cancer diagnosis. The purpose of this study was to: (1) identify and compare latent class subgroups based on four highly prevalent symptoms (pain, fatigue, sleep disturbance, and depression), and (2) examine the differences in sociodemographic and clinical factors in the identified latent classes across the seven cancer types (i.e., prostate, non-small cell lung, non-Hodgkin’s lymphoma, breast, uterine, cervical, and colorectal cancer).

Methods

This study is a cross-sectional secondary analysis of data obtained from the My-Health study in partnership with four Surveillance, Epidemiology, and End Results (SEER) cancer registries located in California (two), Louisiana, and New Jersey. The sample included 4,762 cancer survivors 6-13 months following diagnosis of one of the seven cancer types mentioned. Latent class profile analysis was used.

Results

Subjects were primarily young (59% age 21-64 years), Caucasian (41%), married/cohabitating (58%) and unemployed (55%). The number and types of symptom subgroups varied across these seven cancer populations: four-subgroups were the common in prostate, lung, non-Hodgkin’s lymphoma, and breast cancer survivors. Unmarried, low education, and unemployment status were associated with high risk of symptom burden across the cancer types.

Conclusion

Identifying symptom subgroups by cancer diagnosis has the potential to develop innovative and effective targeted interventions in cancer survivors. Further research is needed to establish extensive knowledge in symptom clustering between treatment regimens, and short-term and long-term cancer survivors.
Appendix
Available only for authorised users
Literature
12.
go back to reference Vermunt JK, Magidson J (2002) Latent class cluster analysis. In: Hagenaars JA, McCutcheon AL (eds) Applied latent class analysis. Cambridge University Press, Cambridge, pp 89–106CrossRef Vermunt JK, Magidson J (2002) Latent class cluster analysis. In: Hagenaars JA, McCutcheon AL (eds) Applied latent class analysis. Cambridge University Press, Cambridge, pp 89–106CrossRef
16.
go back to reference Jensen RE, Moinpour CM, Keegan THM et al (2016) The Measuring Your Health Study: Leveraging Community-Based Cancer Registry Recruitment to Establish a Large, Diverse Cohort of Cancer Survivors for Analyses of Measurement Equivalence and Validity of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Short Form Items. Psychol Test Assess Model 58:99–117 Jensen RE, Moinpour CM, Keegan THM et al (2016) The Measuring Your Health Study: Leveraging Community-Based Cancer Registry Recruitment to Establish a Large, Diverse Cohort of Cancer Survivors for Analyses of Measurement Equivalence and Validity of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Short Form Items. Psychol Test Assess Model 58:99–117
19.
go back to reference Rothrock NE, Cook KF, O'Connor M, Cella D, Smith AW, Yount SE (2019) Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting. Qual Life Res 28(12):3355–3362. https://doi.org/10.1007/s11136-019-02261-2CrossRefPubMedPubMedCentral Rothrock NE, Cook KF, O'Connor M, Cella D, Smith AW, Yount SE (2019) Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting. Qual Life Res 28(12):3355–3362. https://​doi.​org/​10.​1007/​s11136-019-02261-2CrossRefPubMedPubMedCentral
20.
go back to reference Muthén LK, Muthén BO (2021) Mplus Version 8.6. Muthén & Muthén Muthén LK, Muthén BO (2021) Mplus Version 8.6. Muthén & Muthén
21.
go back to reference Corp IBM (2021) IBM SPSS Statistics for Windows, Version 28.0. IBM Corp Corp IBM (2021) IBM SPSS Statistics for Windows, Version 28.0. IBM Corp
36.
Metadata
Title
Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis
Authors
Lena J. Lee
Claire J. Han
Leorey Saligan
Gwenyth R. Wallen
Publication date
01-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08489-0

Other articles of this Issue 5/2024

Supportive Care in Cancer 5/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine